Drug name - Edarbi

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7157584 ARBOR PHARMS LLC Benzimidazole derivative and use thereof
May, 2025

(2 years from now)

CN101381366A ARBOR PHARMS LLC Benzimidazole Derivative And Use As Aii Receptor Antagonist
Feb, 2025

(2 years from now)

CN101381366B ARBOR PHARMS LLC Benzimidazole Derivatives And Their Pharmaceutical Use
Feb, 2025

(2 years from now)

CN1946717A ARBOR PHARMS LLC Benzimidazole Derivative And Its Use
Feb, 2025

(2 years from now)

CN100503605C ARBOR PHARMS LLC Benzimidazole Derivatives And Their Use As A Ii Receptor Antagonists
Feb, 2025

(2 years from now)

IN242537B ARBOR PHARMS LLC Benzimidazole Derivative And A Process For The Preparation Thereof
Feb, 2025

(2 years from now)

IN200602785P2 ARBOR PHARMS LLC Benzimidazole Derivative And Use Thereof
Feb, 2025

(2 years from now)

EP2119715A1 ARBOR PHARMS LLC Benzimidazole Derivative And Its Use As Aii Receptor Antagonist
Feb, 2025

(2 years from now)

EP2119715B1 ARBOR PHARMS LLC Benzimidazole Derivative And Its Use As Aii Receptor Antagonist
Feb, 2025

(2 years from now)

EP1857457A3 ARBOR PHARMS LLC Benzimidazole Derivative And Its Use As Aii Receptor Antagonist
Feb, 2025

(2 years from now)

EP1857457B1 ARBOR PHARMS LLC Benzimidazole Derivative And Its Use As Aii Receptor Antagonist
Feb, 2025

(2 years from now)

EP1857457A2 ARBOR PHARMS LLC Benzimidazole Derivative And Its Use As Aii Receptor Antagonist
Feb, 2025

(2 years from now)

EP1718641A2 ARBOR PHARMS LLC Benzimidazole Derivative And Its Use As A Ii Receptor Antagonist
Dec, 2026

(4 years from now)

EP1718641B1 ARBOR PHARMS LLC Benzimidazole Derivative And Its Use As A Ii Receptor Antagonist
Dec, 2026

(4 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7572920 ARBOR PHARMS LLC Benzimidazole derivative and use as a II receptor antagonist Jan, 2025

(2 years from now)

US9066936 ARBOR PHARMS LLC Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a pH control agent Mar, 2028

(5 years from now)

Drugs and Companies using AZILSARTAN KAMEDOXOMIL ingredient

Treatment: Treatment of hypertension

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 40MG MEDOXOMIL TABLET;ORAL Prescription
EQ 80MG MEDOXOMIL TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.